New drug cocktail aims to shrink colon tumors before surgery
NCT ID NCT03026140
Summary
This study is testing whether giving short-term immunotherapy before surgery can help control early-stage colon cancer. Patients receive one of several drug combinations for 6-12 weeks before their tumor is surgically removed. The main goals are to see if the treatment is safe, if it shrinks the tumor, and if it helps prevent the cancer from coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Catharina Ziekenhuis
RECRUITINGEindhoven, Netherlands
Contact
-
Haga ziekenhuis
NOT_YET_RECRUITINGThe Hague, Netherlands
Contact
-
Marieke van de Belt
RECRUITINGAmsterdam, 1066CX, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
OLVG
RECRUITINGAmsterdam, Netherlands
Contact
-
Spaarne Ziekenhuis
RECRUITINGHaarlem, Netherlands
Contact
-
Tergooi
NOT_YET_RECRUITINGHilversum, Netherlands
Contact
Conditions
Explore the condition pages connected to this study.